539 related articles for article (PubMed ID: 24069552)
1. The involvement of the JAK-STAT signaling pathway in chronic inflammatory skin disease atopic dermatitis.
Bao L; Zhang H; Chan LS
JAKSTAT; 2013 Jul; 2(3):e24137. PubMed ID: 24069552
[TBL] [Abstract][Full Text] [Related]
2. Potential Natural Biomolecules Targeting JAK/STAT/SOCS Signaling in the Management of Atopic Dermatitis.
Kopalli SR; Annamneedi VP; Koppula S
Molecules; 2022 Jul; 27(14):. PubMed ID: 35889539
[TBL] [Abstract][Full Text] [Related]
3. The JAK/STAT Pathway and Its Selective Inhibition in the Treatment of Atopic Dermatitis: A Systematic Review.
Tsiogka A; Kyriazopoulou M; Kontochristopoulos G; Nicolaidou E; Stratigos A; Rigopoulos D; Gregoriou S
J Clin Med; 2022 Jul; 11(15):. PubMed ID: 35956047
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal Stem Cells and Extracellular Vesicles Derived from Canine Adipose Tissue Ameliorates Inflammation, Skin Barrier Function and Pruritus by Reducing JAK/STAT Signaling in Atopic Dermatitis.
Kim SY; Yoon TH; Na J; Yi SJ; Jin Y; Kim M; Oh TH; Chung TW
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563259
[TBL] [Abstract][Full Text] [Related]
5. A novel, topical, nonsteroidal, TRPV1 antagonist, PAC-14028 cream improves skin barrier function and exerts anti-inflammatory action through modulating epidermal differentiation markers and suppressing Th2 cytokines in atopic dermatitis.
Lee JH; Choi CS; Bae IH; Choi JK; Park YH; Park M
J Dermatol Sci; 2018 Apr; ():. PubMed ID: 29752146
[TBL] [Abstract][Full Text] [Related]
6. Off-label use of Baricitinib improves moderate and severe atopic dermatitis in China through inhibiting MAPK and PI3K/Akt/mTOR pathway via targeting JAK-STAT signaling of CD4
Chen S; Li C; Tu Z; Cai T; Zhang X; Wang L; Tian R; Huang J; Gong Y; Yang X; Wu Z; He S; He W; Wang D
Front Pharmacol; 2024; 15():1324892. PubMed ID: 38487164
[TBL] [Abstract][Full Text] [Related]
7. Innovation in Atopic Dermatitis: From Pathogenesis to Treatment.
Munera-Campos M; Carrascosa JM
Actas Dermosifiliogr (Engl Ed); 2020 Apr; 111(3):205-221. PubMed ID: 31964499
[TBL] [Abstract][Full Text] [Related]
8. Igalan from Inula helenium (L.) suppresses the atopic dermatitis-like response in stimulated HaCaT keratinocytes via JAK/STAT3 signaling.
Dao TTP; Song K; Kim JY; Kim YS
Inflamm Res; 2020 Mar; 69(3):309-319. PubMed ID: 32002586
[TBL] [Abstract][Full Text] [Related]
9. Update on the Pathogenesis and Therapy of Atopic Dermatitis.
Li H; Zhang Z; Zhang H; Guo Y; Yao Z
Clin Rev Allergy Immunol; 2021 Dec; 61(3):324-338. PubMed ID: 34338977
[TBL] [Abstract][Full Text] [Related]
10. The Use of JAK/STAT Inhibitors in Chronic Inflammatory Disorders.
Caiazzo G; Caiazzo A; Napolitano M; Megna M; Potestio L; Fornaro L; Parisi M; Luciano MA; Ruggiero A; Testa A; Castiglione F; Patruno C; Quaranta M; Fabbrocini G
J Clin Med; 2023 Apr; 12(8):. PubMed ID: 37109202
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of 5,6-dihydroergosteol-glucoside on atopic dermatitis-like skin lesions via suppression of NF-κB and STAT activation.
Jung M; Lee TH; Oh HJ; Kim H; Son Y; Lee EH; Kim J
J Dermatol Sci; 2015 Sep; 79(3):252-61. PubMed ID: 26100037
[TBL] [Abstract][Full Text] [Related]
12. Gardenia jasminoides extract without crocin improved atopic dermatitis-like skin lesions via suppression of Th2-related cytokines in Dfe-induced NC/Nga mice.
Park SH; An JE; Jang S; Kim JY; Lee JW; Kim HK
J Ethnopharmacol; 2019 Sep; 241():112015. PubMed ID: 31173875
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory Skin Diseases: Focus on the Role of Suppressors of Cytokine Signaling (SOCS) Proteins.
Cianciulli A; Calvello R; Porro C; Lofrumento DD; Panaro MA
Cells; 2024 Mar; 13(6):. PubMed ID: 38534350
[TBL] [Abstract][Full Text] [Related]
14. Novel Therapeutic Targets for the Treatment of Atopic Dermatitis.
Tsuji G; Yamamura K; Kawamura K; Kido-Nakahara M; Ito T; Nakahara T
Biomedicines; 2023 Apr; 11(5):. PubMed ID: 37238974
[TBL] [Abstract][Full Text] [Related]
15. JAK Inhibitors for Atopic Dermatitis: An Update.
He H; Guttman-Yassky E
Am J Clin Dermatol; 2019 Apr; 20(2):181-192. PubMed ID: 30536048
[TBL] [Abstract][Full Text] [Related]
16. Bakuchicin attenuates atopic skin inflammation.
Lim JS; Kim JY; Lee S; Choi JK; Kim EN; Choi YA; Jang YH; Jeong GS; Kim SH
Biomed Pharmacother; 2020 Sep; 129():110466. PubMed ID: 32768955
[TBL] [Abstract][Full Text] [Related]
17. JAK/STAT pathway modulation: Does it work in dermatology?
Gündüz Ö
Dermatol Ther; 2019 May; 32(3):e12903. PubMed ID: 30964573
[TBL] [Abstract][Full Text] [Related]
18. Atopic dermatitis induces the expansion of thymus-derived regulatory T cells exhibiting a Th2-like phenotype in mice.
Moosbrugger-Martinz V; Tripp CH; Clausen BE; Schmuth M; Dubrac S
J Cell Mol Med; 2016 May; 20(5):930-8. PubMed ID: 26931745
[TBL] [Abstract][Full Text] [Related]
19. IL-4 up-regulates epidermal chemotactic, angiogenic, and pro-inflammatory genes and down-regulates antimicrobial genes in vivo and in vitro: relevant in the pathogenesis of atopic dermatitis.
Bao L; Shi VY; Chan LS
Cytokine; 2013 Feb; 61(2):419-25. PubMed ID: 23207180
[TBL] [Abstract][Full Text] [Related]
20. Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis.
Suárez-Fariñas M; Dhingra N; Gittler J; Shemer A; Cardinale I; de Guzman Strong C; Krueger JG; Guttman-Yassky E
J Allergy Clin Immunol; 2013 Aug; 132(2):361-70. PubMed ID: 23777851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
